Healthcare provider profile · identity verified

Phyllis Lee, MD

Family Practice · OSHKOSH, WI · NPI 1124010749

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	373	54
Eliquis	Apixaban	316	39
Furosemide	Furosemide	282	67
Pantoprazole Sodium	Pantoprazole Sodium	246	54
Warfarin Sodium	Warfarin Sodium	242	17
Atorvastatin Calcium	Atorvastatin Calcium	235	70
Gabapentin	Gabapentin	230	53
Amlodipine Besylate	Amlodipine Besylate	210	43
Potassium Chloride	Potassium Chloride	209	48
Sertraline Hcl	Sertraline Hcl	187	30
Metoprolol Succinate	Metoprolol Succinate	185	45
Allopurinol	Allopurinol	138	25
Losartan Potassium	Losartan Potassium	136	34
Metoprolol Tartrate	Metoprolol Tartrate	136	26
Lisinopril	Lisinopril	135	28
Myrbetriq	Mirabegron	127	17
Pravastatin Sodium	Pravastatin Sodium	126	16
Escitalopram Oxalate	Escitalopram Oxalate	116	19
Quetiapine Fumarate	Quetiapine Fumarate	113	13
Mirtazapine	Mirtazapine	111	23
Prednisone	Prednisone	102	14
Famotidine	Famotidine	97	26
Bumetanide	Bumetanide	94	17
Carvedilol	Carvedilol	88	22
Omeprazole	Omeprazole	83	26
Tamsulosin Hcl	Tamsulosin Hcl	81	27
Citalopram Hbr	Citalopram Hydrobromide	79	suppressed
Trazodone Hcl	Trazodone Hcl	79	22
Duloxetine Hcl	Duloxetine Hcl	78	24
Donepezil Hcl	Donepezil Hcl	76	suppressed
Ropinirole Hcl	Ropinirole Hcl	73	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	70	12
Levetiracetam	Levetiracetam	68	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	66	17
Clopidogrel	Clopidogrel Bisulfate	63	16
Rosuvastatin Calcium	Rosuvastatin Calcium	63	19
Simvastatin	Simvastatin	62	17
Lorazepam	Lorazepam	61	11
Jardiance	Empagliflozin	57	12
Insulin Lispro Kwikpen U-100	Insulin Lispro	56	17
Januvia	Sitagliptin Phosphate	53	suppressed
Latanoprost	Latanoprost	52	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	50	15
Spironolactone	Spironolactone	49	15
Buspirone Hcl	Buspirone Hcl	48	suppressed
Midodrine Hcl	Midodrine Hcl	47	12
Risperidone	Risperidone	43	suppressed
Amiodarone Hcl	Amiodarone Hcl	42	suppressed
Klor-Con M20	Potassium Chloride	40	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	16
Metformin Hcl	Metformin Hcl	40	suppressed
Divalproex Sodium	Divalproex Sodium	39	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	38	suppressed
Finasteride	Finasteride	37	suppressed
Fluticasone Propionate	Fluticasone Propionate	37	16
Hydralazine Hcl	Hydralazine Hcl	37	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	36	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	35	34
Bupropion Hcl Sr	Bupropion Hcl	32	suppressed
Calcitriol	Calcitriol	32	11
Metoclopramide Hcl	Metoclopramide Hcl	32	suppressed
Nystatin	Nystatin	32	19
Tramadol Hcl	Tramadol Hcl	32	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	24
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	29	12
Loperamide	Loperamide Hcl	29	20
Entresto	Sacubitril/Valsartan	28	suppressed
Lactulose	Lactulose	28	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Anastrozole	Anastrozole	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	18
Sucralfate	Sucralfate	21	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	20	suppressed
Xifaxan	Rifaximin	19	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Cephalexin	Cephalexin	17	13
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Folic Acid	Folic Acid	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Easy Touch Safety Pen Needle	Pen Needle, Diabetic, Safety	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	14
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	15	suppressed
Glipizide	Glipizide	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Ondansetron Odt	Ondansetron	15	11
Alendronate Sodium	Alendronate Sodium	14	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Torsemide	Torsemide	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Trospium Chloride	Trospium Chloride	14	suppressed
Azathioprine	Azathioprine	13	suppressed
Balsalazide Disodium	Balsalazide Disodium	13	suppressed
Cefadroxil	Cefadroxil	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Cyclosporine	Cyclosporine	13	suppressed
Febuxostat	Febuxostat	13	suppressed
Insulin Aspart Flexpen	Insulin Aspart	13	suppressed
Lumigan	Bimatoprost	13	suppressed
Mesalamine	Mesalamine	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Admelog Solostar	Insulin Lispro	12	suppressed
Atenolol	Atenolol	12	suppressed
Diazepam	Diazepam	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	11
Farxiga	Dapagliflozin Propanediol	12	suppressed
Montelukast Sodium	Montelukast Sodium	12	suppressed
Nystop	Nystatin	12	11
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Colchicine	Colchicine	11	suppressed
Digoxin	Digoxin	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Metolazone	Metolazone	11	suppressed
Minocycline Hcl	Minocycline Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error